Global Generic Active Pharmaceutical Ingredients Market Research Report 2019

Table of Contents

Executive Summary

1 Generic Active Pharmaceutical Ingredients Market Overview

• 1.1 Product Overview and Scope of Generic Active Pharmaceutical Ingredients
• 1.2 Generic Active Pharmaceutical Ingredients Segment by Type
  • 1.2.1 Global Generic Active Pharmaceutical Ingredients Production Growth Rate Comparison by Type (2014-2025)
  • 1.2.2 Monoclonal Antibodies
  • 1.2.3 Hormones
  • 1.2.4 Cytokines
  • 1.2.5 Fusion Proteins
  • 1.2.6 Therapeutic Enzymes
  • 1.2.7 Vaccines
  • 1.2.8 Blood Factors
• 1.3 Generic Active Pharmaceutical Ingredients Segment by Application
  • 1.3.1 Generic Active Pharmaceutical Ingredients Consumption Comparison by Application (2014-2025)
  • 1.3.2 Oncology
  • 1.3.3 Diabetes
  • 1.3.4 Cardiovascular Disease
  • 1.3.5 CNS and Neurological Disorders
  • 1.3.6 Endocrinology
  • 1.3.7 Others
• 1.3 Global Generic Active Pharmaceutical Ingredients Market by Region
  • 1.3.1 Global Generic Active Pharmaceutical Ingredients Market Size Region
  • 1.3.2 North America Status and Prospect (2014-2025)
  • 1.3.3 Europe Status and Prospect (2014-2025)
  • 1.3.4 China Status and Prospect (2014-2025)
  • 1.3.5 Japan Status and Prospect (2014-2025)
  • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
  • 1.3.7 India Status and Prospect (2014-2025)
• 1.4 Global Generic Active Pharmaceutical Ingredients Market Size
  • 1.4.1 Global Generic Active Pharmaceutical Ingredients Revenue (2014-2025)
  • 1.4.2 Global Generic Active Pharmaceutical Ingredients Production (2014-2025)

2 Global Generic Active Pharmaceutical Ingredients Market Competition by Manufacturers

• 2.1 Global Generic Active Pharmaceutical Ingredients Production Market Share by Manufacturers (2014-2019)
• 2.2 Global Generic Active Pharmaceutical Ingredients Revenue Share by Manufacturers (2014-2019)
• 2.3 Global Generic Active Pharmaceutical Ingredients Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers Generic Active Pharmaceutical Ingredients Production Sites, Area Served, Product Types
• 2.5 Generic Active Pharmaceutical Ingredients Market Competitive Situation and Trends
  • 2.5.1 Generic Active Pharmaceutical Ingredients Market Concentration Rate
  • 2.5.2 Generic Active Pharmaceutical Ingredients Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global Generic Active Pharmaceutical Ingredients Production Market Share by Regions

• 3.1 Global Generic Active Pharmaceutical Ingredients Production Market Share by Regions
• 3.2 Global Generic Active Pharmaceutical Ingredients Revenue Market Share by Regions (2014-2019)
• 3.3 Global Generic Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America Generic Active Pharmaceutical Ingredients Production
  • 3.4.1 North America Generic Active Pharmaceutical Ingredients Production Growth Rate (2014-2019)
  • 3.4.2 North America Generic Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe Generic Active Pharmaceutical Ingredients Production
  • 3.5.1 Europe Generic Active Pharmaceutical Ingredients Production Growth Rate (2014-2019)
  • 3.5.2 Europe Generic Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China Generic Active Pharmaceutical Ingredients Production (2014-2019)
  • 3.6.1 China Generic Active Pharmaceutical Ingredients Production Growth Rate (2014-2019)
  • 3.6.2 China Generic Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan Generic Active Pharmaceutical Ingredients Production (2014-2019)
  • 3.7.1 Japan Generic Active Pharmaceutical Ingredients Production Growth Rate (2014-2019)
  • 3.7.2 Japan Generic Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Generic Active Pharmaceutical Ingredients Consumption by Regions

• 4.1 Global Generic Active Pharmaceutical Ingredients Consumption by Regions
• 4.2 North America Generic Active Pharmaceutical Ingredients Consumption (2014-2019)
• 4.3 Europe Generic Active Pharmaceutical Ingredients Consumption (2014-2019)
• 4.4 China Generic Active Pharmaceutical Ingredients Consumption (2014-2019)
• 4.5 Japan Generic Active Pharmaceutical Ingredients Consumption (2014-2019)

5 Global Generic Active Pharmaceutical Ingredients Production, Revenue, Price Trend by Type

• 5.1 Global Generic Active Pharmaceutical Ingredients Production Market Share by Type (2014-2019)
• 5.2 Global Generic Active Pharmaceutical Ingredients Revenue Market Share by Type (2014-2019)
• 5.3 Global Generic Active Pharmaceutical Ingredients Price by Type (2014-2019)
• 5.4 Global Generic Active Pharmaceutical Ingredients Production Growth by Type (2014-2019)

6 Global Generic Active Pharmaceutical Ingredients Market Analysis by Applications

• 6.1 Global Generic Active Pharmaceutical Ingredients Consumption Market Share by Application (2014-2019)
• 6.2 Global Generic Active Pharmaceutical Ingredients Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Generic Active Pharmaceutical Ingredients Business

• 7.1 Pfizer, Inc. (U.S.)
  • 7.1.1 Pfizer, Inc. (U.S.) Generic Active Pharmaceutical Ingredients Production Sites and Area Served
  • 7.1.2 Generic Active Pharmaceutical Ingredients Product Introduction, Application and Specification
  • 7.1.3 Pfizer, Inc. (U.S.) Generic Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 Novartis International AG (Switzerland)
  • 7.2.1 Novartis International AG (Switzerland) Generic Active Pharmaceutical Ingredients Production Sites and Area Served
  • 7.2.2 Generic Active Pharmaceutical Ingredients Product Introduction, Application and Specification
  • 7.2.3 Novartis International AG (Switzerland) Generic Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 Sanofi (France)
  • 7.3.1 Sanofi (France) Generic Active Pharmaceutical Ingredients Production Sites and Area Served
  • 7.3.2 Generic Active Pharmaceutical Ingredients Product Introduction, Application and Specification
  • 7.3.3 Sanofi (France) Generic Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 Boehringer Ingelheim (Germany)
  • 7.4.1 Boehringer Ingelheim (Germany) Generic Active Pharmaceutical Ingredients Production Sites and Area Served
  • 7.4.2 Generic Active Pharmaceutical Ingredients Product Introduction, Application and Specification
  • 7.4.3 Boehringer Ingelheim (Germany) Generic Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.5 Bristol-Myers Squibb (U.S.)
  • 7.5.1 Bristol-Myers Squibb (U.S.) Generic Active Pharmaceutical Ingredients Production Sites and Area Served
  • 7.5.2 Generic Active Pharmaceutical Ingredients Product Introduction, Application and Specification
  • 7.5.3 Bristol-Myers Squibb (U.S.) Generic Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.5.4 Main Business and Markets Served
• 7.6 Teva Pharmaceutical Industries Ltd. (Israel)
  • 7.6.1 Teva Pharmaceutical Industries Ltd. (Israel) Generic Active Pharmaceutical Ingredients Production Sites and Area Served
  • 7.6.2 Generic Active Pharmaceutical Ingredients Product Introduction, Application and Specification
  • 7.6.3 Teva Pharmaceutical Industries Ltd. (Israel) Generic Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.6.4 Main Business and Markets Served
• 7.7 Eli Lilly and Company (U.S.)
  • 7.7.1 Eli Lilly and Company (U.S.) Generic Active Pharmaceutical Ingredients Production Sites and Area Served
  • 7.7.2 Generic Active Pharmaceutical Ingredients Product Introduction, Application and Specification
  • 7.7.3 Eli Lilly and Company (U.S.) Generic Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.7.4 Main Business and Markets Served
• 7.8 GlaxoSmithKline plc (U.K.)
  • 7.8.1 GlaxoSmithKline plc (U.K.) Generic Active Pharmaceutical Ingredients Production Sites and Area Served
  • 7.8.2 Generic Active Pharmaceutical Ingredients Product Introduction, Application and Specification
  • 7.8.3 GlaxoSmithKline plc (U.K.) Generic Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.8.4 Main Business and Markets Served
• 7.9 Merck & Co., Inc. (U.S.)
  • 7.9.1 Merck & Co., Inc. (U.S.) Generic Active Pharmaceutical Ingredients Production Sites and Area Served
  • 7.9.2 Generic Active Pharmaceutical Ingredients Product Introduction, Application and Specification
  • 7.9.3 Merck & Co., Inc. (U.S.) Generic Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.9.4 Main Business and Markets Served
• 7.10 AbbVie Inc. (U.S.)
  • 7.10.1 AbbVie Inc. (U.S.) Generic Active Pharmaceutical Ingredients Production Sites and Area Served
  • 7.10.2 Generic Active Pharmaceutical Ingredients Product Introduction, Application and Specification
  • 7.10.3 AbbVie Inc. (U.S.) Generic Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.10.4 Main Business and Markets Served

8 Generic Active Pharmaceutical Ingredients Manufacturing Cost Analysis

• 8.1 Generic Active Pharmaceutical Ingredients Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Generic Active Pharmaceutical Ingredients
• 8.4 Generic Active Pharmaceutical Ingredients Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 Generic Active Pharmaceutical Ingredients Distributors List
• 9.3 Generic Active Pharmaceutical Ingredients Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global Generic Active Pharmaceutical Ingredients Market Forecast

• 11.1 Global Generic Active Pharmaceutical Ingredients Production, Revenue Forecast
  • 11.1.1 Global Generic Active Pharmaceutical Ingredients Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global Generic Active Pharmaceutical Ingredients Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global Generic Active Pharmaceutical Ingredients Price and Trend Forecast (2019-2025)
• 11.2 Global Generic Active Pharmaceutical Ingredients Production Forecast by Regions (2019-2025)
  • 11.2.1 North America Generic Active Pharmaceutical Ingredients Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe Generic Active Pharmaceutical Ingredients Production, Revenue Forecast (2019-2025)
  • 11.2.3 China Generic Active Pharmaceutical Ingredients Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan Generic Active Pharmaceutical Ingredients Production, Revenue Forecast (2019-2025)
• 11.3 Global Generic Active Pharmaceutical Ingredients Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America Generic Active Pharmaceutical Ingredients Consumption Forecast (2019-2025)
  • 11.3.2 Europe Generic Active Pharmaceutical Ingredients Consumption Forecast (2019-2025)
  • 11.3.3 China Generic Active Pharmaceutical Ingredients Consumption Forecast (2019-2025)
  • 11.3.4 Japan Generic Active Pharmaceutical Ingredients Consumption Forecast (2019-2025)
• 11.4 Global Generic Active Pharmaceutical Ingredients Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global Generic Active Pharmaceutical Ingredients Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List